Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) in the Asia Pacific region (Round Table Forum)

Abstract Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) have become increasingly important in an era of rising costs, patient safety concerns and evidence-based health care. CE and EBM research in the Asia Pacific region have grown significantly. However, there are three main challenge...

Full description

Saved in:
Bibliographic Details
Published in:Preventive medicine 2013, Vol.57, p.S5-S7
Main Authors: Su, Tin Tin, Bulgiba, Awang M, Sampatanukul, Pichet, Sastroasmoro, Sudigdo, Chang, Peter, Tharyan, Prathap, Lin, Vivian, Wong, Yut Lin
Format: Article
Language:English
Subjects:
Asia Pacific
Australia
Clinical epidemiology
Epidemiology - organization & administration
Epidemiology - standards
Evidence-based medicine
Evidence-Based Medicine - organization & administration
Evidence-Based Medicine - standards
Evidence-based policy
Health Policy
Humans
Indonesia
Internal Medicine
International Cooperation
Malaysia
Taiwan
Thailand
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Clinical Epidemiology (CE) and Evidence-Based Medicine (EBM) have become increasingly important in an era of rising costs, patient safety concerns and evidence-based health care. CE and EBM research in the Asia Pacific region have grown significantly. However, there are three main challenges such as linking evidence to practice and policy; developing a strong collaborative network; and a need for resources and technical expertise to produce evidence. The Cochrane Collaboration is a possible solution to resolve above challenges identified, particularly the challenge of transforming evidence to practice. In addition, training can be carried out to enhance technical expertise in the region and there is also the promising potential that collaborations could extend beyond systematic reviews. To improve the adoption of evidence-based health policy, selection of the best evidence for the right audience and focusing on the relevant issues through appropriate methodology are essential. Information on effectiveness and cost effectiveness needs to be highlighted for policy makers. The way forward to strengthen research and capacity building is to establish the Asia Pacific Consortium for CE and EBM. The consortium would help to create mutually rewarding scientific research and collaborations that will augur well for advances in CE and EBM.
ISSN:0091-7435
1096-0260
DOI:10.1016/j.ypmed.2013.04.009